Skip to main content

Table 1 Comparison of NUSTART recruitment characteristics of patients followed-up at 2–3 years post-ART initiation versus those not followed-up (due to loss to follow-up, lack of data or death)a

From: Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study

 

Followed-up at 2–3 years post ART (n = 273)

Lost to follow-up or died before 2–3 years-post ART (n = 431)

P-valueb

Lost to follow-up (n = 145)

Died (n = 286)

Age at baseline, year

38.9 (9.7)

35.9 (9.7)

38.3 (9.9)

0.01e

Female, n (%)

178 (65.2)

76 (52.4)

133 (45.6)

<0.0001

Marital status, n (%)c

 Married

122 (44.7)

48 (33.3)

114 (39.9)

0.16

 Widow/widower

38 (13.9)

17 (11.8)

40 (14.0)

 

 Divorced/separated

94 (34.4)

59 (41.0)

96 (33.5)

 

 Single

19 (7.0)

19 (13.2)

34 (11.9)

 

 Lives with partner

0 (0.0)

1 (0.7)

2 (0.7)

 

Occupation, n (%)c

 Salaried

6 (2.2)

8 (5.6)

10 (3.5)

0.16

 Self-employed

237 (86.8)

119 (82.6)

251 (87.8)

 

 Housewife

19 (7.0)

6 (4.1)

10 (3.5)

 

 Student

2 (0.7)

3 (2.1)

1 (0.3)

 

 Unemployed

9 (3.3)

8 (5.6)

14 (4.9)

 

Education level, n (%)c

 None

81 (29.6)

31 (21.5)

82 (28.7)

0.01

 Primary

176 (64.5)

104 (72.2)

192 (67.1)

 

 Secondary

16 (5.9)

5 (3.5)

11 (3.9)

 

 University/Tertiary

0 (0)

4 (2.8)

1 (0.3)

 

Social economic status, n (%)

 Lowest

58 (21.3)

19 (13.1)

64 (22.4)

0.10

 Low

64 (23.4)

24 (16.6)

62 (21.7)

 

 Middle

54 (19.8)

28 (19.3)

50 (17.5)

 

 High

47 (17.2)

39 (26.9)

55 (19.2)

 

 Highest

50 (18.3)

35 (24.1)

55 (19.2)

 

Fat mass index (kg/m2)d

2.9 (0.8)

2.7 (0.8)

2.5 (0.8)

<0.0001f

Fat-free mass index (kg/m2)d

14.0 (0.9)

14.1 (0.8)

13.9 (1.0)

0.14

Body mass index (kg/m2)

16.7 (1.2)

16.7 (1.2)

16.2 (1.5)

0.0001g

CD4 count (cells/μL)

127 (99.7)

116 (102.8)

113 (106.8)

0.29

Tuberculosis treatment, n (%)

63 (23.1)

49 (33.8)

48 (16.8)

<0.0001

  1. aData are mean ± SD unless specified as n (%)
  2. bcomparison done by oneway ANOVA test for continuous outcomes and chi-squared test for categorical outcomes
  3. c1 patient missing in the lost-to follow-up group
  4. d25 patients in the followed-up group, 16 in the lost to follow-up group, and 68 in the died group missing
  5. eBonferroni test showed differences between the followed-up group and the lost to follow-up group (P = 0.009) and the lost to follow-up group and the died group (P = 0.049)
  6. fBonferroni test showed differences between the followed-up group and the died group (P < 0.0001)
  7. gBonferroni test showed differences between the followed-up group and the died group (P < 0.0001) and the lost to follow-up group and the died group (P < 0.0001)